The increase in the intracellular vGlut1 (at least in the HL) suggests that diabetes could selectively interfere with the traffic of glutamate toward efferent terminals, with a consequent decreased capability of diabetic hippocampus to generate LTP. The gene discussed is SLC17A7; the disease is diabetes mellitus.